(Reuters) -Hims and Hers Health missed Wall Street estimates for third-quarter profit on Monday, hit by increased product costs and reduced unit sales in the telehealth company's weight-loss business.
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback